-
Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money
The US Internal Revenue Code has numerous regulations which must be adhered to in order […]
-
Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals
Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with […]
-
Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech
Continuing a trend that began in 2017, this year has seen the rise of big […]
-
Whitepaper: Focus on the Antibiotics Market
The antibiotics market is expected to reach USD 57.0 billion by 2024. Rising prevalence of […]